tirzepatide brain fog made headlines for weight loss. But that's not why longevity doctors are paying attention. As a dual GIP/GLP-1 receptor agonist, it works on pathways that go far beyond metabolism. The data tirzepatide brain fog Starting GLP-1
Description
What happens when you stop taking Wegovy
In the head-to-head comparison of tirzepatide versus semaglutide, the hazard ratio was 1.06 (95% CI 0.95 to 1.18)
The complexity of dose regimens, the patients perception of administration, and fear of injections may affect the rate of commencing injectable treatment
It is available as a private script and NOT on the PBS
Appetite and Energy Intake Effects Tirzepatide also works by curbing appetite and reducing calorie intake
This may indicate that the peptide has degraded or that the solution is contaminated
